
Anne Paakinaho
Postdoctoral Researcher
PhD (Pharm), BSc (Biosciences)
School of Pharmacy, Faculty of Health Sciences
[email protected] | +358 40 355 3986
Research groups
Publications
8/8 items-
The EU project Real4Reg: unlocking real-world data with AI
Peltner, Jonas; Becker, Cornelia; Wicherski, Julia; Wortberg, Silja; Aborageh, Mohamed; Costa, Inês; Ehrenstein, Vera; Fernandes, Joana; Heß, Steffen; Horváth-Puhó, Erzsébet; Korcinska Handest, Monika Roberta; Lentzen, Manuel; Maguire, Peggy; Meedom, Niels Henrik; Moore, Rebecca; Moore, Vanessa; Nagy, Dávid; McNamara, Hillary; Paakinaho, Anne; Pfeifer, Kerstin; Pylkkänen, Liisa; Rajamaki, Blair; Reviers, Evy; Röthlein, Christoph; Russek, Martin; Silva, Célia; De Valck, Dirk; Vo, Thuan; Bräuner, . 2025. Health research policy and systems. 23: . 27 A1 Journal article (refereed), original research -
Disease-modifying antirheumatic drugs and inhaled β2-adrenoceptor agonists and risk of Parkinson’s disease: a nationwide register-based study
Paakinaho, Anne. 2024. Publications of the University of Eastern Finland. Dissertations in Health Sciences G5 Doctoral dissertation (article) -
Statin use and the risk of Parkinson's disease in persons with diabetes: A nested case–control study
Honkamaa, Kim; Paakinaho, Anne; Tolppanen, Anna-Maija; Kettunen, Raimo; Hartikainen, Sirpa; Tiihonen, Miia. 2024. British journal of clinical pharmacology. 90: 1463-1470 A1 Journal article (refereed), original research -
Hospitalization and the Risk of Initiation of Antipsychotics in Persons With Parkinson's Disease
Pirttilä, Aki; Tiihonen, Miia; Paakinaho, Anne; Hartikainen, Sirpa; Tolppanen, Anna-Maija. 2023. Journal of the american medical directors association. 24: 1290-1296.e4 A1 Journal article (refereed), original research -
β2-Adrenoceptor Agonists in Asthma or Chronic Obstructive Pulmonary Disease and Risk of Parkinson’s Disease: Nested Case-Control Study
Paakinaho, Anne; Tiihonen, Miia; Koskela, Heikki; Koponen, Marjaana; Tiihonen, Jari; Hartikainen, Sirpa; Tolppanen, Anna-Maija. 2023. Clinical epidemiology. 15: 695-705 A1 Journal article (refereed), original research -
Disease-Modifying Antirheumatic Drugs and Risk of Parkinson Disease
Paakinaho, Anne; Koponen, Marjaana; Tiihonen, Miia; Kauppi, Markku; Hartikainen, Sirpa; Tolppanen, Anna-Maija. 2022. Neurology. 98: e1273-e1281 A1 Journal article (refereed), original research -
Identification of Drugs Associated with Lower Risk of Parkinson’s Disease Using a Systematic Screening Approach in a Nationwide Nested Case–Control Study
Koponen, Marjaana; Paakinaho, Anne; Lin, Julian; Hartikainen, Sirpa; Tolppanen, Anna-Maija. 2022. Clinical epidemiology. 14: 1217-1227 A1 Journal article (refereed), original research -
Incidence of muscle relaxant use in relation to diagnosis of Parkinson's disease
Paakinaho, Anne; Karttunen, Niina; Koponen, Marjaana; Taipale, Heidi; Tolppanen, Anna-Maija; Hartikainen, Sirpa; Tiihonen, Miia. 2020. International journal of clinical pharmacy. 42: 336-340 A1 Journal article (refereed), original research